Datta Meghe Institute of Higher Education & Research (DMIHER), Wardha, Maharashtra.
Datta Meghe Institute of Higher Education & Research (DMIHER), Wardha, Maharashtra.
Datta Meghe Institute of Higher Education & Research (DMIHER), Wardha, Maharashtra.
Generalized anxiety disorder (GAD) is a prevalent mental health condition characterized by excessive worry and anxiety, often impairing daily functioning and quality of life. The occurrence of Generalized Anxiety Disorder (GAD) is higher in females than in males. Traditional approaches to diagnosing and managing GAD rely heavily on subjective assessments, including self-report questionnaires and clinician evaluations, and resource-intensive therapeutic interventions such as cognitive-behavioral therapy (CBT) and medication. However, recent advancements in artificial intelligence (AI) have opened new and innovative avenues for enhancing mental healthcare delivery. AI-driven tools, including machine learning algorithms, natural language processing (NLP), and wearable sensors, offer promising solutions for the early and accurate diagnosis, personalized treatment, and remote monitoring of patients with GAD. AI technologies enable the analysis of speech, text, and physiological data to detect anxiety symptoms with remarkable precision, allowing for earlier interventions and more accurate clinical assessments. Furthermore, AI-powered chatbots, virtual reality therapies, and digital platforms provide scalable and cost-effective treatment options, improving accessibility to mental health services, especially in underserved or rural areas. Despite these benefits, the integration of AI in GAD care faces several challenges, including concerns about data privacy, algorithmic biases, and ethical considerations regarding the replacement of human therapists. This review explores the applications of AI in diagnosing and managing GAD, emphasizing its potential to transform mental health care practices. Key findings from the literature highlight AI’s ability to increase diagnostic accuracy, improve treatment efficiency, and increase patient engagement, whereas future research must address regulatory, implementation, and ethical barriers to fully realize its potential impact on GAD care.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 The Authors